CVS Health Co. (NYSE:CVS) Shares Acquired by NewSquare Capital LLC

NewSquare Capital LLC grew its position in CVS Health Co. (NYSE:CVS) by 3.3% during the 4th quarter, HoldingsChannel.com reports. The firm owned 101,367 shares of the pharmacy operator’s stock after acquiring an additional 3,199 shares during the quarter. NewSquare Capital LLC’s holdings in CVS Health were worth $7,892,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Atticus Wealth Management LLC increased its holdings in CVS Health by 149.0% during the 4th quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock worth $29,000 after purchasing an additional 219 shares during the last quarter. Cornerstone Planning Group LLC increased its holdings in shares of CVS Health by 111.5% in the 3rd quarter. Cornerstone Planning Group LLC now owns 461 shares of the pharmacy operator’s stock valued at $32,000 after acquiring an additional 243 shares during the last quarter. ZRC Wealth Management LLC increased its holdings in shares of CVS Health by 400.0% in the 4th quarter. ZRC Wealth Management LLC now owns 500 shares of the pharmacy operator’s stock valued at $39,000 after acquiring an additional 400 shares during the last quarter. Coston McIsaac & Partners increased its holdings in shares of CVS Health by 42.6% in the 4th quarter. Coston McIsaac & Partners now owns 539 shares of the pharmacy operator’s stock valued at $42,000 after acquiring an additional 161 shares during the last quarter. Finally, Tennessee Valley Asset Management Partners bought a new stake in shares of CVS Health in the 4th quarter valued at approximately $50,000. 80.66% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on CVS shares. Leerink Partnrs restated an “outperform” rating on shares of CVS Health in a research note on Monday, February 26th. SVB Leerink started coverage on CVS Health in a research note on Monday, February 26th. They set an “outperform” rating and a $88.00 price objective for the company. Royal Bank of Canada lowered their price objective on CVS Health from $86.00 to $84.00 and set an “outperform” rating for the company in a research note on Thursday, February 8th. Barclays started coverage on CVS Health in a research note on Wednesday, March 6th. They set an “equal weight” rating and a $78.00 price objective for the company. Finally, Cantor Fitzgerald restated an “overweight” rating and set a $87.00 price objective on shares of CVS Health in a research note on Wednesday, April 10th. Four equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat, CVS Health presently has an average rating of “Moderate Buy” and an average target price of $89.44.

Insider Buying and Selling

In related news, EVP Prem S. Shah sold 29,473 shares of CVS Health stock in a transaction on Friday, February 16th. The stock was sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the completion of the sale, the executive vice president now directly owns 39,765 shares of the company’s stock, valued at $3,059,916.75. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.24% of the stock is owned by insiders.

CVS Health Trading Down 1.6 %

Shares of CVS stock traded down $1.13 on Tuesday, reaching $68.50. 8,441,734 shares of the stock were exchanged, compared to its average volume of 10,757,553. The stock has a market cap of $86.34 billion, a PE ratio of 10.74, a P/E/G ratio of 0.92 and a beta of 0.52. CVS Health Co. has a one year low of $64.41 and a one year high of $83.25. The company has a debt-to-equity ratio of 0.77, a current ratio of 0.86 and a quick ratio of 0.63. The stock has a 50 day moving average price of $75.13 and a 200 day moving average price of $73.77.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share for the quarter, topping analysts’ consensus estimates of $2.01 by $0.11. The company had revenue of $93.81 billion during the quarter, compared to the consensus estimate of $90.58 billion. CVS Health had a return on equity of 15.25% and a net margin of 2.33%. The firm’s quarterly revenue was up 11.9% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.99 earnings per share. Equities research analysts forecast that CVS Health Co. will post 8.32 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 1st. Investors of record on Monday, April 22nd will be paid a dividend of $0.665 per share. The ex-dividend date is Friday, April 19th. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.88%. CVS Health’s dividend payout ratio (DPR) is presently 41.18%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.